Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-13 09:55 am Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Prosight Management LP | 0 0% | -948,012 (Position Closed) | View |
2024-02-13 09:54 am Sale | 13G | MEIRAGTX HLDGS PLC MGTX | Prosight Management LP | 4,052,714 6.4% | -28,090 (-0.69%) | View |
2024-02-13 09:50 am Sale | 13G | KEZAR LIFE SCIENCES INC KZR | Prosight Management LP | 3,365,333 4.6% | -707,896 (-17.38%) | View |
2024-02-13 09:50 am Sale | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | Prosight Management LP | 0 0% | -3,150,000 (Position Closed) | View |
2024-02-13 09:47 am Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management LP | 6,471,800 8% | 2,167,282 (+50.35%) | View |
2024-02-13 09:26 am Sale | 13G | ORIC PHARMACEUTICALS INC ORIC | Prosight Management LP | 1,578,263 2.9% | -702,515 (-30.80%) | View |
2023-12-29 5:47 pm Purchase | 13G | SHATTUCK LABS INC STTK | Prosight Management LP | 2,782,797 5.9% | 2,782,797 (New Position) | View |
2023-09-01 08:40 am Purchase | 13G | NANOSTRING TECHNOLOGIES INC CO NSTG | Prosight Management LP | 3,150,000 6.6% | 3,150,000 (New Position) | View |
2023-06-09 8:15 pm Purchase | 13G | ORIC PHARMACEUTICALS INC ORIC | Prosight Management LP | 2,280,778 5.1% | 2,280,778 (New Position) | View |
2023-05-12 7:37 pm Purchase | 13G | MEIRAGTX HLDGS PLC MGTX | Prosight Management LP | 4,080,804 6.9% | 4,080,804 (New Position) | View |
2023-04-20 6:20 pm Purchase | 13G | KEZAR LIFE SCIENCES INC KZR | Prosight Management LP | 4,073,229 5.8% | 4,073,229 (New Position) | View |
2023-04-19 9:48 pm Purchase | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Prosight Management LP | 948,012 4.9% | 948,012 (New Position) | View |
2023-04-14 5:45 pm Purchase | 13G | ADC THERAPEUTICS SA SHS ADCT | Prosight Management LP | 4,304,518 5.3% | 4,304,518 (New Position) | View |
2022-02-14 09:27 am Sale | 13G | EXICURE INC XCUR | Prosight Management LP | 2,503,704 2.3% | -2,480,561 (-49.77%) | View |
2021-08-20 09:01 am Purchase | 13G | EXICURE INC XCUR | Prosight Management LP | 4,984,265 5.7% | 4,984,265 (New Position) | View |
2021-02-12 08:30 am Sale | 13G | ALDEYRA THERAPEUTICS, INC ALDX | Prosight Management LP | 908,488 2.3% | -875,545 (-49.08%) | View |
2020-02-25 09:00 am Purchase | 13G | ALDEYRA THERAPEUTICS, INC ALDX | Prosight Management LP | 1,784,033 6.3% | 1,784,033 (New Position) | View |
2020-02-14 3:00 pm Sale | 13G | TELIGENT INC TLGT | Prosight Management LP | 1,484,527 2.8% | -2,063,080 (-58.15%) | View |